Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Corvus Pharmaceuticals Inc. (CRVS)

5.26 -0.22 (-4.01%)

12-14 16:00

Open:

5.5

Pre. Close:

5.48

High:

5.56

Low:

4.93

Volume:

45,262

Market Cap:

154M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.571 - 5.602

5.602 - 5.637

Low:

4.849 - 4.881

4.881 - 4.916

Close:

5.196 - 5.255

5.255 - 5.319

Technical analysis  (as of: 2018-12-14 4:23:13 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 8.14     One year: 9.61

Support:

Support1: 4.93    Support2: 4.10

Resistance:

Resistance1: 6.97    Resistance2: 8.22

Pivot:

5.94

Moving Averages:

MA(5): 5.63     MA(20): 6.13

MA(100): 8.47     MA(250): 9.61

MACD:

MACD(12,26): -0.52     Signal(12,26,9): -0.51

%K %D:

%K(14,3): 22.90     %D(3): 22.12

RSI:

RSI(14): 29.19

52-Week:

High: 13.91  Low: 4.93  Change(%): -43.4

Average Vol(K):

3-Month: 8726  10-Days 6392

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CRVS has closed below the lower band by 4.8%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 27.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-11-01T17:20:31-04:00
Corvus Pharmaceuticals beats by $0.10

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

29.28

Shares Float (M)

29.02

% Held by Insiders

0.90

% Held by Institutions

111.40

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-1.970

EPS Est. Current Year

-3.180

EPS Est. Next Year

-3.410

EPS Est. Next Quarter

-0.840

Forward EPS

-3.286

Book Value (p.s.)

1.460

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-41.7

Return on Equity (ttm)

-45.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-43.71

Levered Free Cash Flow (M)

-26.61

Valuation

P/E

-2.67

P/E Growth Ratio

-0.04

P/BV

3.60

P/S

P/CF

-3.52

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.